Recent developments in neuronal nicotinic acetylcholine receptor modulators

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Expert Opinion on Therapeutic Patents

• Publication date

  1998-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1517/13543776.8.8.991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Downregulation of Nicotinic Receptor Function after Chronic Nicotine Infusion 1

  2006cited by this paper
• Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.

  1998cited by this paper
• ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.

  1998cited by this paper
• Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

  1998cited by this paper
• Neuronal nicotinic acetylcholine receptors as targets for drug discovery.

  1997cited by this paper
• Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

  1997cited by this paper
• ABT-089: An Orally Effective Cholinergic Channel Modulator (ChCM) with Cognitive Enhancement and Neuroprotective Action

  1997cited by this paper
• Alzheimer's disease and related dementias: prospects for treatment.

  1997cited by this paper
• Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.

  1997cited by this paper
• ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.

  1997cited by this paper
• ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.

  1997cited by this paper
• The molecular biology of neuronal nicotinic acetylcholine receptors

  1997cited by this paper
• Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.

  1997cited by this paper
• In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418.

  1996cited by this paper
• Section Review: Central & Peripheral Nervous Systems: Cholinergic channel modulators as a novel therapeutic strategy for Alzheimer's disease

  1996cited by this paper
• Projection structure of the nicotinic acetylcholine receptor: distinct conformations of the alpha subunits.

  1996cited by this paper
• (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.

  1996cited by this paper
• Neuronal nicotinic acetylcholine receptors.

  1996cited by this paper
• RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

  1996cited by this paper
• Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.

  1996cited by this paper
• Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.

  1996cited by this paper
• Pharmacology of novel nicotinic analogs

  1996cited by this paper
• Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure—affinity investigation

  1996cited by this paper
• Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

  1995cited by this paper
• Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

  1995cited by this paper
• Synthesis and structure-activity relationships of 2′-(R) and (S) pyrrolidine-modified analogs of the cholinergic channel activator, ABT-418

  1995cited by this paper
• Phenyl pyrrolidine analogues as potent nicotinic acetylcholine receptor (nAChR) ligands

  1995cited by this paper
• Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

  1995cited by this paper
• Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor.

  1995cited by this paper
• A short, efficient chiral synthesis of a novel cholinergic channel activator, ABT-418 [(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole], from (S)-pyroglutamic acid

  1995cited by this paper
• Human α 7 nicotinic acetylcholine receptor responses to novel ligands

  1995cited by this paper
• Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.

  1995cited by this paper
• [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.

  1995cited by this paper
• A Short, Efficient Synthesis of the Novel Cholinergic Channel Activator, ABT 418, from L-Proline

  1995cited by this paper
• Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.

  1995cited by this paper
• Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal Synaptosomes

  1994cited by this paper
• Effects of anabaseine‐related analogs on rat brain nicotinic receptor binding and on avoidance behaviors

  1994cited by this paper
• Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.

  1994cited by this paper
• Ligands for brain cholinergic channel receptors: synthesis and in vitro characterization of novel isoxazoles and isothiazoles as bioisosteric replacements for the pyridine ring in nicotine.

  1994cited by this paper
• Alkyl‐modified side chain variants of anatoxin‐a: A series of potent nicotinic agonists

  1994cited by this paper
• Synthesis and Biological Evaluation of (±)-Epibatidine and the Congeners

  1994cited by this paper
• A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain.

  1994cited by this paper
• Pharmacological effects of epibatidine optical enantiomers.

  1994cited by this paper
• Synthesis and evaluation of nicotine analogs as neuronal nicotinic acetylcholine receptor ligands.

  1994cited by this paper
• (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.

  1994cited by this paper
• Cytoprotective actions of 2,4‐dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons

  1994cited by this paper
• Synthesis and structure-activity relationships of pyrrolidine-modified analogs of the potent cholinergic channel activator, ABT 418

  1994cited by this paper
• α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells

  1994cited by this paper
• Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.

  1994cited by this paper
• (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

  1994cited by this paper
• Epibatidine, a potent analgetic and nicotinic agonist.

  1994cited by this paper
• The diversity of neuronal nicotinic acetylcholine receptors.

  1993cited by this paper
• Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium

  1993cited by this paper
• Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine.

  1993cited by this paper
• Nicotinic acetylcholine receptor at 9 A resolution.

  1993cited by this paper
• Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms.

  1993cited by this paper
• Functional diversity of neuronal nicotinic acetylcholine receptors.

  1993cited by this paper
• (+)‐Anatoxin‐a Is a Potent Agonist at Neuronal Nicotinic Acetylcholine Receptors

  1993cited by this paper
• Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.

  1993cited by this paper
• Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line.

  1993cited by this paper
• Agonist pharmacology of the neuronal α7 nicotinic receptor expressed in Xenopus oocytes

  1993cited by this paper
• Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an ecuadoran poison frog

  1992cited by this paper
• Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.

  1991cited by this paper
• Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.

  1991cited by this paper
• Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.

  1991cited by this paper
• Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily

  1990cited by this paper
• Neurotoxins Distinguish Between Different Neuronal Nicotinic Acetylcholine Receptor Subunit Combinations

  1990cited by this paper
• Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists.

  1990cited by this paper
• Nicotinic Modulation of [3H]Dopamine Release from Striatal Synaptosomes: Pharmacological Characterisation

  1990cited by this paper
• Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites.

  1990cited by this paper
• Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster.

  1990cited by this paper
• Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.

  1989cited by this paper
• Beta 3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain.

  1989cited by this paper
• The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: β4

  1989cited by this paper
• A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671

  1989cited by this paper
• Primary structure and expression of β2: A novel subunit of neuronal nicotinic acetylcholine receptors

  1988cited by this paper
• Methyllycaconitine and (+)‐anatoxin‐a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems

  1988cited by this paper
• High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.

  1988cited by this paper
• Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor.

  1988cited by this paper
• Identification of putative high affinity nicotinic receptors on cultured cortical neurons.

  1988cited by this paper
• Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system.

  1987cited by this paper
• Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family.

  1987cited by this paper
• Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.

  1986cited by this paper
• Molecular Biology of Muscle and Neural Acetylcholine Receptors

  1986cited by this paper
• [3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors.

  1986cited by this paper
• Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor α-subunit

  1986cited by this paper
• Identification of a nicotinic acetylcholine receptor on neurons using an alpha-neurotoxin that blocks receptor function

  1986cited by this paper
• Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin

  1985cited by this paper
• Structure and Action of Nemertine Toxins

  1985cited by this paper
• Expression of functional acetylcholine receptor from cloned cDNAs

  1984cited by this paper
• Primary structures of β- and δ-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences

  1983cited by this paper
• Bridged nicotines. Synthesis of cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo[2,3-f]quinoline

  1983cited by this paper
• Structural homology of Torpedo californica acetylcholine receptor subunits

  1983cited by this paper
• Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence

  1982cited by this paper
• Transformations involving the pyrrolidine ring of nicotine

  1980cited by this paper
• Palladium catalyzed hydrolysis of tertiary amines with water

  1979cited by this paper
• Aberrant syntheses in higher plants. 3. Synthesis of 4-methylnicotine and an examination of its possible biosynthesis from 4-methylnicotinic acid in Nicotiana tabacum

  1978cited by this paper
• Ligand responses of alpha-bungarotoxin binding sites from skeletal muscle and optic lobe of the chick.

  1978cited by this paper
• Synthetic analogues of nicotine VI1,2. Nicotine substituted in the 5-position.

  1977cited by this paper
• Physicochemical properties of biological interest and structure of nicotine and its related compounds

  1971cited by this paper

• Synthesis of new alkynyl containing 9-azabicyclo[4.2.1]nonatrienes from diynes and azepines

  2020cites this paper
• Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.

  2009cites this paper
• Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.

  2008cites this paper
• Unique spirocyclopiperazinium salt III: further investigation of monospirocyclopiperazinium (MSPZ) salts as potential analgesics.

  2007cites this paper
• SYNTHESIS AND EVALUATION OF PYRIDINIUM DERIVATIVES AS CENTRAL NERVOUS SYSTEM NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

  2006cites this paper
• Novel enantiopure ferrugininoids active as nicotinic agents: synthesis and radioligand binding studies.

  2004cites this paper
• Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

  2004cites this paper
• Synthesis and analgesic activity of hydrochlorides and quaternary ammoniums of epibatidine incorporated with amino acid ester.

  2003cites this paper
• 3D QSAR Analyses-Guided Rational Design of Novel Ligands for the (α4)2(β2)3 Nicotinic Acetylcholine Receptor

  2003cites this paper
• Synthesis of a [2-pyridinyl-18F]-labelled fluoro derivative of (-)-cytisine as a candidate radioligand for brain nicotinic alpha4beta2 receptor imaging with PET.

  2003cites this paper
• Unique spirocyclopiperazinium salt I: synthesis and structure-activity relationship of spirocyclopiperazinium salts as analgesics.

  2003cites this paper
• Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities.

  2003cites this paper
• Unique spirocyclopiperazinium salt. Part 2: synthesis and structure-activity relationship of dispirocyclopiperazinium salts as analgesics.

  2003cites this paper
• Synthesis and evaluation of conformationally restricted pyridino N‐alkylated nicotine analogs as nicotinic acetylcholine receptor antagonists

  2002cites this paper
• Syntheses and evaluation of pyridazine and pyrimidine containing bioisosteres of (+/-)-pyrido[3.4-b]homotropane and pyrido-[3.4-b]tropane as novel nAChR ligands.

  2002cites this paper
• bis-azaaromatic quaternary ammonium analogues: Ligands for α4β2* and α7* subtypes of neuronal nicotinic receptors

  2002cites this paper
• Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.

  2002cites this paper
• New developments in psychopharmacology of attention deficit hyperactivity disorder

  2001cites this paper
• Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.

  2001cites this paper
• Therapeutic agents for attention deficit disorders

  2000cites this paper
• Recent developments in neuronal nicotinic acetylcholine receptor antagonists

  2000cites this paper
• Therapeutic agents for attention deficit disorders

  2000cites this paper
• (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.

  2000cites this paper
• Pyrrolidines bearing a quaternary α-stereogenic center. Part 1: Synthesis of analogs of ABT-418, a powerful nicotinic agonist

  1999cites this paper
• D QSAR Analyses-Guided Rational Design of Novel Ligands for the ( r 4 ) 2 ( â 2 ) 3 Nicotinic Acetylcholine Receptor

  year unknowncites this paper
• octane-3 , 5 ′-oxazolidin-2 ′-one ] , a Conformationally Restricted Analogue of Acetylcholine , Is a Highly Selective Full Agonist at the r 7 Nicotinic Acetylcholine Receptor

  year unknowncites this paper